Japan’s Nichi-Iko Pharmaceutical bought Illinois-based Sagent Pharmaceuticals in 2016 to get a foothold in the U.S. Now Nichi-Iko is establishing a solid U.S. manufacturing footprint by acquiring a plant in North Carolina. More: Sagent buys U.S. sterile injectables plant in
read moreThe psoriasis field has been fiercely competitive for a few years now, and drugmakers used last weekend’s American Association of Dermatology annual meeting to trumpet new data they hoped would help them get a leg up on rivals. Below, we’ve
read moreYears into a standoff between Vertex Pharmaceuticals and NHS England over cystic fibrosis drug prices, the company’s top brass is set to participate in a parliamentary hearing focused on pricing negotiations. More: Vertex CEO, CCO head for U.K. hearing on Orkambi
read moreEli Lilly CEO David Ricks may have missed last week’s Senate hearing on drug prices, but he apparently received the message on rising insulin prices. Lilly is now planning a half-priced version of its big-selling insulin Humalog and once again
read moreJust when it appeared the FDA was close to purging the U.S. drug supply of potential cancer-causing impurities in sartan blood pressure drugs, another massive recall has been launched. This time it is for an entirely new contaminant. More: A
read moreNightstar Therapeutics has agreed to be acquired by Biogen. More: Syncona’s Nightstar Therapeutics to be bought by Biogen for 7 million Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals